MedPath

Treatment of Complex Regional Pain Syndrome, a Long-term Follow-up

Completed
Conditions
Chronic Pain
Complex Regional Pain Syndromes
Interventions
Behavioral: Multimodal rehabilitation
Registration Number
NCT04597866
Lead Sponsor
Uppsala University
Brief Summary

Complex regional pain syndrome, CRPS, is an uncommon but often very disabling chronic pain syndrome characterized by, beside pain: sensory disturbances, peripheral autonomic changes and inflammatory features. The diagnosis is subdivided in CRPS type 1 where no nerve injury has been identified, and CRPS type 2 when a major nerve injury has been verified.

A combination of exposure in vivo, a form of behaviour therapy where the patient is gradually confronted with avoided movements and activities, and interventions directly targeting a hypothesized cortical reorganisation is an interesting novel approach for treating CRPS.

The present study consists of (1) a qualitative interview study with 10-15 subjects that has received this form of treatment, in order to better understand their experience and effects of the treatment, and (2) a case series with long-term follow-up of 3-5 subjects that received the treatment för 5-8 years ago, in order to study the long term effects of the treatment.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
10
Inclusion Criteria
  • Has participated in multimodal treatment for CRPS at Uppsala University Hospital
Exclusion Criteria
  • Other serious physical or mental condition

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
CRPSMultimodal rehabilitation-
Primary Outcome Measures
NameTimeMethod
Diagnosis1 day

Whether the subject still fulfill diagnostic criteria for CRPS

Subjective experience1 day

A qualitative interview targeting the subjects own experience of the treatment and its effect

Secondary Outcome Measures
NameTimeMethod
Acceptance of pain1 day (0-156, higher scores mean a better outcome)

Measured with the Chronic Pain Acceptance Questionnaire, CPAQ (0-156, higher scores mean a better outcome)

Level of pain1 day

Subjective level of pain on a Likert-scale 0-10 (NRS)

Fear of pain1 day (0-52, lower scores mean a better outcome)

Measured with the Tampa Scale of Kinesiophobia, TSK (0-52, lower scores mean a better outcome)

Subjective experience of quality of life 31 day

Life Satisfaction Questionnaire, LiSat 11 (11-66, higher scores means a better outcome)

Neglect of the affected limb1 day (0-36, lower scores mean a better outcome)

Measured with a five item questionnaire (0-36, lower scores mean a better outcome)

Subjective experience of quality of life1 day

Quality of life, measured with the RAND-36 (0-100, higher scores mean a better outcome)

Global impression of change1 day

Global impression of change measured with a single question (0-6, higher scores mean a better outcome)

Pain catastrophizing1 day (0-52, lower scores mean a better outcome)

Measured with Pain Catastrophizing Scale, PCS (0-52, lower scores mean a better outcome)

Avoidance of activities1 day (0-100, lower scores mean a better outcome)

Measured with the Photograph Series of Daily Activities, PHODA (0-100, lower scores mean a better outcome)

Subjective experience of quality of life 21 day

EuroQol 5D, EQ-5D (0-15, higher scores means a better outcome)

Trial Locations

Locations (1)

Uppsala University

🇸🇪

Uppsala, Sweden

© Copyright 2025. All Rights Reserved by MedPath